Biotechnology
- 1057.386
- +3.104+0.29%
Earnings Call Summary | CSL LTD SPON ADR EACH REPR 0.5 ORD(CSLLY.US) Q4 2024 Earnings Conference
US HHS Says 8 Labs Sign Royalty-Free Agreements For H5N1 Tests
Bit Origin Sinks 30%+ as Recent Rally Fades, But TeraWulf and Other Crypto Stocks Gain as Bitcoin Rises
AU Morning Wrap: Australian Shares Slip as Inflation Worries Heighten; Cettire Tumbles 40%
AU Evening Wrap: ASX 200 Rises 0.3%, Ends Week Up 0.9%
AU Evening Wrap: Australian Shares Close Steady as Financials and Real Estate Stocks Rise
AU Evening Wrap: Australia Shares Slip 0.3% as Commodity Stocks Fall
AU Weekly Wrap | May Unemplyment Rate Falls; Telix Pharmaceuticals Shares Sink on Unexpected Nasdaq News
AU Morning Wrap: ASX Slips; Deterra Falls Amid Lithium Pivot Bid
AU Evening Wrap: Australia Shares Rise 0.7% on Broad-Based Gains
Starting Point for Business Recovery: CSL Company Outlook
AU Morning Wrap: Australian Shares Hold Gains Despite Commodity Price Weakness; GDP Ahead
AU Evening Wrap: Australia Shares Fall 0.3% Amid Commodity Weakness
AU Evening Wrap: Australia Shares Rise 0.8% as Bank Stocks Gain
AU Evening Wrap: Australia Shares Rise 1%, Paring Recent Losses
AU Morning Wrap: ASX 200 Rises by Broad Buying; ANZ Sells Stake in Malaysian Bank
AU Evening Wrap: Australia Shares Tumble 1.3% as Rate-Cut Hopes Fade
AU Evening Wrap: Australia Shares Rise 0.8% Amid Bank, Gold Gains
Market Mover | shares of Neuren Pharmaceuticals jump 11% on positive Phase 2 trial results
AU Evening Wrap: Australia Shares Fall 1.1% Amid Broad-Based Declines